MONECO Advisors LLC Has $2.25 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

MONECO Advisors LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 46.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,447 shares of the healthcare conglomerate’s stock after selling 3,929 shares during the quarter. MONECO Advisors LLC’s holdings in UnitedHealth Group were worth $2,250,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. DecisionPoint Financial LLC boosted its stake in UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after purchasing an additional 62 shares in the last quarter. Highline Wealth Partners LLC acquired a new position in UnitedHealth Group in the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC acquired a new position in UnitedHealth Group in the third quarter worth $57,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 7.3 %

Shares of UnitedHealth Group stock opened at $465.58 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The business has a 50-day moving average of $519.27 and a two-hundred day moving average of $560.48. The company has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the company earned $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research note on Friday, January 10th. Oppenheimer upped their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.